SEC Tracker
Get the app

Seres Therapeutics MCRB

Seres Therapeutics CEO resigns

Item 5.02 Executive or director change

Form
8-K
Filed
Importance
Major
  1. Marella Thorell resigned as CFO on Oct 22, 2026
  2. Will provide advisory services post-resignation

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Seres Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Oncolytics Biotech ONCY public float $72M, Jun 30, 2025
  2. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025
  3. Volitionrx VNRX public float $73M, Jun 30, 2025
  4. Macrogenics MGNX public float $74M, Jun 30, 2025
  5. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025